Title |
Are we overestimating the loss of beta cells in type 2 diabetes?
|
---|---|
Published in |
Diabetologia, November 2013
|
DOI | 10.1007/s00125-013-3098-3 |
Pubmed ID | |
Authors |
Lorella Marselli, Mara Suleiman, Matilde Masini, Daniela Campani, Marco Bugliani, Farooq Syed, Luisa Martino, Daniele Focosi, Fabrizio Scatena, Francesco Olimpico, Franco Filipponi, Pellegrino Masiello, Ugo Boggi, Piero Marchetti |
Abstract |
Previous work has demonstrated that beta cell amount (whether measured as beta cell mass, beta cell volume or insulin-positive area) is decreased in type 2 diabetes; however, recent findings suggest that mechanisms other than death may contribute to beta cell failure in this disease. To better characterise beta cell mass and function in type 2 diabetes, we performed morphological, ultra-structural and functional studies using histological samples and isolated islets. |
X Demographics
The data shown below were collected from the profiles of 10 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 1 | 10% |
Italy | 1 | 10% |
Netherlands | 1 | 10% |
Ukraine | 1 | 10% |
Germany | 1 | 10% |
United States | 1 | 10% |
Unknown | 4 | 40% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 8 | 80% |
Scientists | 1 | 10% |
Practitioners (doctors, other healthcare professionals) | 1 | 10% |
Mendeley readers
The data shown below were compiled from readership statistics for 110 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 2% |
Sweden | 1 | <1% |
Germany | 1 | <1% |
France | 1 | <1% |
Unknown | 105 | 95% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 19 | 17% |
Student > Ph. D. Student | 15 | 14% |
Student > Master | 11 | 10% |
Student > Bachelor | 9 | 8% |
Professor > Associate Professor | 6 | 5% |
Other | 20 | 18% |
Unknown | 30 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Biochemistry, Genetics and Molecular Biology | 25 | 23% |
Medicine and Dentistry | 22 | 20% |
Agricultural and Biological Sciences | 12 | 11% |
Nursing and Health Professions | 5 | 5% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
Other | 10 | 9% |
Unknown | 32 | 29% |
Attention Score in Context
This research output has an Altmetric Attention Score of 14. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 September 2022.
All research outputs
#2,346,148
of 23,330,477 outputs
Outputs from Diabetologia
#1,220
of 5,123 outputs
Outputs of similar age
#22,324
of 212,813 outputs
Outputs of similar age from Diabetologia
#10
of 46 outputs
Altmetric has tracked 23,330,477 research outputs across all sources so far. Compared to these this one has done well and is in the 89th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,123 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 23.0. This one has done well, scoring higher than 76% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 212,813 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 89% of its contemporaries.
We're also able to compare this research output to 46 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 78% of its contemporaries.